Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pacific Biosciences of California, Inc. Second Quarter 2018 Financial Results Call

PACB

MENLO PARK, Calif., July 23, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its Second Quarter 2018 Financial Results on Thursday, August 2, 2018, at 4:30pm Eastern Time.

The call will be webcast and may be accessed at Pacific Biosciences’ website at:  http://investor.pacificbiosciences.com/.

Date:  August 2, 2018

Time:  4:30pm ET

Listen via Internet:  http://investor.pacificbiosciences.com/

Toll-free:  888.366.7247

International:  707.287.9330

Conference ID: 2075988

Replay:  http://investor.pacificbiosciences.com

About Pacific Biosciences
Pacific Biosciences of California, Inc. (NASDAQ:PACB) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) technology, Pacific Biosciences’ products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences’ technology provides high accuracy, ultra-long reads, uniform coverage, and the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com.

Contact:  Pacific Biosciences
Trevin Rard
650.521.8450
ir@pacificbiosciences.com

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today